PubMed

Assessing the impact of the Australia-United States Free Trade Agreement on Australian and global medicines policy.

Faunce T, Doran E, Henry D, Drahos P, Searles A, Pekarsky B, Neville W.

Global Health. 2005 Oct 6;1:15.PMID: 16209703 [PubMed]Related articlesFree article

Will the Australia-United States Free Trade Agreement undermine the Pharmaceutical Benefits Scheme?

Harvey KJ, Faunce TA, Lokuge B, Drahos P.

Med J Aust. 2004 Sep 6;181(5):256-9.PMID: 15347273 [PubMed - indexed for MEDLINE]Related articlesFree article

The UNESCO Bioethics Declaration 'social responsibility' principle and cost-effectiveness price evaluations for essential medicines.

Faunce TA.

Monash Bioeth Rev. 2005 Jul;24(3):10-9.PMID: 16302317 [PubMed - indexed for MEDLINE]Related articles

Challenges for Australia's Bio/Nanopharma Policies: trade deals, public goods and reference pricing in sustainable industrial renewal.

Faunce TA.

Aust New Zealand Health Policy. 2007 Jun 1;4:9.PMID: 17543114 [PubMed]Related articlesFree article

Free trade in pharmaceuticals.

Outterson MK.

Med J Aust. 2004 Sep 6;181(5):260-1.PMID: 15347274 [PubMed - indexed for MEDLINE]Related articlesFree article

Australian pharmaceutical policy: price control, equity, and drug innovation in Australia.

Doran E, Alexander Henry D.

J Public Health Policy. 2008 Apr;29(1):106-20.PMID: 18368023 [PubMed - indexed for MEDLINE]Related articles

The PBS in a globalised world: free trade and reference pricing.

Searles A.

Aust Health Rev. 2009 May;33(2):186-91.PMID: 19563307 [PubMed - in process]Related articles

Patents, pills and politics: the Australia-United States Free Trade Agreement and the Pharmaceutical Benefits Scheme.

Harvey K.

Aust Health Rev. 2004 Nov 8;28(2):218-26. Erratum in: Aust Health Rev. 2004 Dec 13;28(3):381. PMID: 15527402 [PubMed - indexed for MEDLINE]Related articles

Toward a treaty on safety and cost-effectiveness of pharmaceuticals and medical devices: enhancing an endangered global public good.

Faunce TA.

Global Health. 2006 Mar 28;2:5.PMID: 16569240 [PubMed]Related articlesFree article

KSR v. Teleflex. Part 2: Impact of U.S Supreme Court Patent Law on Canadian and global systems-based innovation ecologies.

Bouchard RA.

Health Law J. 2007;15:247-94.PMID: 19702185 [PubMed - indexed for MEDLINE]Related articles

TRIPS, the Doha declaration and paragraph 6 decision: what are the remaining steps for protecting access to medicines?

Kerry VB, Lee K.

Global Health. 2007 May 24;3:3.PMID: 17524147 [PubMed]Related articlesFree article

The UK House of Commons report on the influence of the pharmaceutical industry: lessons for equitable access to medicines in Australia.

Faunce TS, Tomossy GF.

Monash Bioeth Rev. 2005 Apr;24(2):38-42.PMID: 16208881 [PubMed - indexed for MEDLINE]Related articles

Policy challenges of nanomedicine for Australia's PBS.

Faunce TA.

Aust Health Rev. 2009 May;33(2):258-67.PMID: 19563314 [PubMed - in process]Related articles

The Pharmaceutical Benefits Scheme 2003-2004.

Harvey KJ.

Aust New Zealand Health Policy. 2005 Jan 12;2(1):2.PMID: 15679896 [PubMed - as supplied by publisher]Related articlesFree article

Addressing legal and political barriers to global pharmaceutical access: options for remedying the impact of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) and the imposition of TRIPS-plus standards.

Cohen-Kohler JC, Forman L, Lipkus N.

Health Econ Policy Law. 2008 Jul;3(Pt 3):229-56.PMID: 18634618 [PubMed - indexed for MEDLINE]Related articles

Evidence-based decision-making within Australia's pharmaceutical benefits scheme.

Lopert R.

Issue Brief (Commonw Fund). 2009 Jul;60:1-13.PMID: 19639714 [PubMed - indexed for MEDLINE]Related articles

Balancing health and industrial policy objectives in the pharmaceutical sector: lessons from Australia.

Morgan S, McMahon M, Greyson D.

Health Policy. 2008 Aug;87(2):133-45. Epub 2008 Mar 4.PMID: 18295927 [PubMed - indexed for MEDLINE]Related articles

Transparency in pricing arrangements for medicines listed on the Australian Pharmaceutical Benefits Scheme.

Robertson J, Walkom EJ, Henry DA.

Aust Health Rev. 2009 May;33(2):192-9.PMID: 19563308 [PubMed - in process]Related articles

Potential impact of AUSFTA on Australia's blood supply.

Bambrick HJ, Faunce TA, Johnston K.

Med J Aust. 2006 Sep 18;185(6):320-3.PMID: 16999673 [PubMed - indexed for MEDLINE]Related articlesFree article

Procedures and methods of benefit assessments for medicines in Germany.

Bekkering GE, Kleijnen J.

Eur J Health Econ. 2008 Nov;9 Suppl 1:5-29.PMID: 18987905 [PubMed - indexed for MEDLINE]Related articles